SCHEMBL6388341

SCHEMBL6388341

O=C(Nc1ccc(Oc2ccnc(C3=NCCN3)c2)cc1)N(c1ccc(Cl)c(C(F)(F)F)c1)N(C(=O)Nc1ccc(Oc2ccnc(-c3nnn[nH]3)c2)cc1)c1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 10/20 0.51
KDR P35968 10/20 0.46
FLT1 P17948 2/20 0.46
BRAF P15056 2/20 0.45
MEN1 O00255 1/20 0.43
PLK4 O00444 1/20 0.43
CIT O14578 1/20 0.43
AURKA O14965 1/20 0.43
MUSK O15146 1/20 0.43
EPHB6 O15197 1/20 0.43
MAPK13 O15264 1/20 0.43
MLNR O43193 1/20 0.43
MAP3K7 O43318 1/20 0.43
RIPK2 O43353 1/20 0.43
DYRK3 O43781 1/20 0.43
PDE6D O43924 1/20 0.43
NR1I2 O75469 1/20 0.43
STK10 O94804 1/20 0.43
CDK14 O94921 1/20 0.43
ABCB11 O95342 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388343 0.90 RAF1 (0.63) RAF1KDRFLT1BRAFMEN1
SCHEMBL6384852 0.85 RAF1 (0.47) RAF1KDRFLT1BRAFMEN1
SCHEMBL3410987 0.82 RAF1 (0.72) RAF1KDRFLT1BRAFMEN1
SCHEMBL3413370 0.81 RAF1 (0.68) RAF1KDRFLT1BRAFMEN1
SCHEMBL13547755 0.76 RAF1 (0.66) RAF1KDRFLT1BRAFHDAC3
SCHEMBL6384853 0.75 RAF1 (0.58) RAF1KDRFLT1BRAFMEN1
SCHEMBL3543215 0.75 RAF1 (0.67) RAF1KDRFLT1BRAFPDGFRB
SCHEMBL3539177 0.74 KDR (0.54) RAF1KDRFLT1BRAFMEN1
SCHEMBL5424304 0.73 RAF1 (0.52) RAF1KDRFLT1BRAFMEN1
SCHEMBL545637 0.73 KDR (0.52) RAF1KDRFLT1BRAFMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603879-A2 SUBSTITUTED PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-12-14 EP claimed
WO-2004078128-A2 SUBSTITUTED PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 WO claimed